CTOR Competitors & Alternatives

Compare Citius Oncology, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

CTOR

Main Stock
$0.69
Tradestie Score
51
Market Cap
$164.52M
Analyst Upside
+478.6%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.16
$711.32M - 59 Compare
ESPR Esperion Therapeutics, Inc.
$3.15
$584.71M - 55 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$36.73
$543.32M - 57 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.30
$237.15M 6.7 63 Compare
BIOA BioAge Labs, Inc. Common Stock
$24.95
$212.23M - 56 Compare
SLXN Silexion Therapeutics Corp Ordinary Shares
$2.57
$11.85M - 48 Compare
IBO Impact BioMedical, Inc.
$0.50
$7.84M - 48 Compare
AMIX Autonomix Medical, Inc. Common Stock
$5.84
$7.25M - 61 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$12.75
$6.53M - 48 Compare
NIVF NewGenIvf Group Limited Class A ordinary shares
$0.52
$4.04M 0.0 47 Compare

Data updated: Jun 30, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry